[{"address1": "5 Science Park", "address2": "395 Winchester Avenue", "city": "New Haven", "state": "CT", "zip": "06511", "country": "United States", "phone": "203 535 1456", "website": "https://www.arvinas.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.", "fullTimeEmployees": 430, "companyOfficers": [{"maxAge": 1, "name": "Dr. John G. Houston Ph.D.", "age": 64, "title": "Chairperson, CEO & President", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 1124624, "exercisedValue": 0, "unexercisedValue": 847759}, {"maxAge": 1, "name": "Mr. Andrew R. Saik", "age": 55, "title": "CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 657193, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela M. Cacace Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 696153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Randy  Teel Ph.D.", "age": 44, "title": "Chief Business Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 711098, "exercisedValue": 0, "unexercisedValue": 331598}, {"maxAge": 1, "name": "Dr. Noah  Berkowitz M.D., Ph.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 747020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Loomis M.B.A.", "age": 50, "title": "VP & Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Boyle", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jared M. Freedberg J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Weiss", "age": 54, "title": "Senior VP & Chief Human Resources Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Sinclair", "title": "Senior Vice President of Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.27, "open": 9.39, "dayLow": 9.3, "dayHigh": 9.775, "regularMarketPreviousClose": 9.27, "regularMarketOpen": 9.39, "regularMarketDayLow": 9.3, "regularMarketDayHigh": 9.775, "payoutRatio": 0.0, "beta": 2.395, "forwardPE": -2.0622318, "volume": 1752577, "regularMarketVolume": 1752577, "averageVolume": 1974667, "averageVolume10days": 2595990, "averageDailyVolume10Day": 2595990, "bid": 7.0, "ask": 11.94, "bidSize": 2, "askSize": 2, "marketCap": 705543040, "fiftyTwoWeekLow": 5.9, "fiftyTwoWeekHigh": 29.61, "allTimeHigh": 108.47, "allTimeLow": 5.9, "priceToSalesTrailing12Months": 1.8925511, "fiftyDayAverage": 7.6278, "twoHundredDayAverage": 10.58135, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -145756912, "profitMargins": -0.19474001, "floatShares": 62175893, "sharesOutstanding": 73417595, "sharesShort": 9587995, "sharesShortPriorMonth": 8321083, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.1306, "heldPercentInsiders": 0.06894, "heldPercentInstitutions": 0.93834996, "shortRatio": 6.98, "shortPercentOfFloat": 0.13270001, "impliedSharesOutstanding": 73417595, "bookValue": 8.324, "priceToBook": 1.154493, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -72600000, "trailingEps": -1.01, "forwardEps": -4.66, "enterpriseToRevenue": -0.391, "enterpriseToEbitda": 1.281, "52WeekChange": -0.6200079, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 9.61, "targetHighPrice": 110.0, "targetLowPrice": 7.0, "targetMeanPrice": 17.88235, "targetMedianPrice": 10.0, "recommendationMean": 2.15, "recommendationKey": "buy", "numberOfAnalystOpinions": 17, "totalCash": 861200000, "totalCashPerShare": 11.73, "ebitda": -113800000, "totalDebt": 9900000, "quickRatio": 5.528, "currentRatio": 5.637, "totalRevenue": 372800000, "debtToEquity": 1.625, "revenuePerShare": 5.146, "returnOnAssets": -0.0671, "returnOnEquity": -0.12005, "grossProfits": 392000000, "freeCashflow": -182237504, "operatingCashflow": -396400000, "revenueGrowth": -0.707, "grossMargins": 1.0515, "ebitdaMargins": -0.30526, "operatingMargins": -3.14732, "financialCurrency": "USD", "symbol": "ARVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 3.66774, "regularMarketPrice": 9.61, "exchange": "NMS", "messageBoardId": "finmb_243040896", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1759532613, "regularMarketTime": 1759521601, "shortName": "Arvinas, Inc.", "longName": "Arvinas, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1538055000000, "postMarketChangePercent": -0.104051, "postMarketPrice": 9.6, "postMarketChange": -0.00999928, "regularMarketChange": 0.339999, "regularMarketDayRange": "9.3 - 9.775", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1974667, "fiftyTwoWeekLowChange": 3.7099996, "fiftyTwoWeekLowChangePercent": 0.62881345, "fiftyTwoWeekRange": "5.9 - 29.61", "fiftyTwoWeekHighChange": -20.0, "fiftyTwoWeekHighChangePercent": -0.67544746, "fiftyTwoWeekChangePercent": -62.000786, "earningsTimestamp": 1754483400, "earningsTimestampStart": 1761654600, "earningsTimestampEnd": 1761654600, "earningsCallTimestampStart": 1754481600, "earningsCallTimestampEnd": 1754481600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.01, "epsForward": -4.66, "epsCurrentYear": -0.97494, "priceEpsCurrentYear": -9.857017, "fiftyDayAverageChange": 1.9821997, "fiftyDayAverageChangePercent": 0.2598652, "twoHundredDayAverageChange": -0.97135067, "twoHundredDayAverageChangePercent": -0.091798365, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.2 - Buy", "cryptoTradeable": false, "displayName": "Arvinas", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]